当前位置:首页 - 行情中心 - 东诚药业(002675) - 财务分析 - 现金流量表

东诚药业

(002675)

  

流通市值:93.44亿  总市值:103.65亿
流通股本:7.43亿   总股本:8.25亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,215,796,362.16608,119,198.82,767,898,800.962,095,780,834.07
  收到的税费返还5,910,623.783,516,592.1265,836,787.6958,599,504.89
  收到其他与经营活动有关的现金41,314,468.9117,050,594.3745,418,554.7148,611,095.55
  经营活动现金流入小计1,263,021,454.85628,686,385.292,879,154,143.362,202,991,434.51
  购买商品、接受劳务支付的现金503,481,160.8279,638,296.38994,764,300.59803,640,810.39
  支付给职工以及为职工支付的现金307,542,225.41182,675,820.95515,676,516.61410,403,134.24
  支付的各项税费139,644,689.4164,952,979.81266,899,287.61202,197,140.59
  支付其他与经营活动有关的现金250,068,015.5132,817,819.68521,963,644.09445,756,021.72
  经营活动现金流出小计1,200,736,091.12660,084,916.822,299,303,748.91,861,997,106.94
  经营活动产生的现金流量净额62,285,363.73-31,398,531.53579,850,394.46340,994,327.57
二、投资活动产生的现金流量:
  收回投资收到的现金443,500,000260,500,0001,144,840,000884,840,000
  取得投资收益收到的现金3,102,214.041,024,660.624,760,198.074,076,770.73
  处置固定资产、无形资产和其他长期资产收回的现金净额53,686.1950541,740.868,761,687.06
  处置子公司及其他营业单位收到的现金净额---115.49-
  收到的其他与投资活动有关的现金806,600818,333.751,320,000220,000
  投资活动现金流入小计447,462,500.23262,343,044.371,151,461,823.44897,898,457.79
  购建固定资产、无形资产和其他长期资产支付的现金180,665,348.0674,296,959.11360,817,831.77202,127,232.34
  投资支付的现金878,157,462.78208,000,0001,345,023,879.451,046,437,917.94
  支付其他与投资活动有关的现金--294,500255,115.49
  投资活动现金流出小计1,058,822,810.84282,296,959.111,706,136,211.221,248,820,265.77
  投资活动产生的现金流量净额-611,360,310.61-19,953,914.74-554,674,387.78-350,921,807.98
三、筹资活动产生的现金流量:
  吸收投资收到的现金--416,981,732.68426,160,000
  取得借款收到的现金878,414,648.92159,689,298.6486,974,381.3464,343,346
  收到其他与筹资活动有关的现金34,571,0002,200,00024,270,00024,054,220.61
  筹资活动现金流入小计912,985,648.92161,889,298.6928,226,113.98914,557,566.61
  偿还债务支付的现金309,620,363.8956,602,165.54704,906,078.12578,270,532.14
  分配股利、利润或偿付利息支付的现金116,761,382.1616,827,553.83110,368,705.9390,095,905.21
  支付其他与筹资活动有关的现金105,481,734.1888,493,722.4626,630,589.9317,306,698.02
  筹资活动现金流出小计531,863,480.23161,923,441.83841,905,373.98685,673,135.37
  筹资活动产生的现金流量净额381,122,168.69-34,143.2386,320,740228,884,431.24
四、汇率变动对现金及现金等价物的影响-4,394,515.87-2,501,209.53-2,391,921.442,482,833.6
五、现金及现金等价物净增加额-172,347,294.06-53,887,799.03109,104,825.24221,439,784.43
  加:期初现金及现金等价物余额844,725,390.32847,078,806.23735,620,565.08735,620,565.08
  期末现金及现金等价物余额672,378,096.26793,191,007.2844,725,390.32957,060,349.51
补充资料:
  净利润82,993,349.34-154,441,271.11-
  资产减值准备16,706,354.23-15,055,905.42-
  固定资产和投资性房地产折旧81,672,316.4-165,039,794.1-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧81,672,316.4-165,039,794.1-
  无形资产摊销9,052,346.22-15,669,917.96-
  长期待摊费用摊销16,564,091.98-21,095,513.48-
  处置固定资产、无形资产和其他长期资产的损失---82,376.19-
  固定资产报废损失191,101.71-412,212.94-
  公允价值变动损失-468,185.23--904,860.26-
  财务费用77,127,278.51-141,044,793.07-
  投资损失-4,123,928.33-16,781,001.75-
  递延所得税-5,825,655.42--34,855,149.38-
  其中:递延所得税资产减少-6,935,415.92--39,991,180.97-
    递延所得税负债增加1,109,760.5-5,136,031.59-
  存货的减少62,083,633.82-112,133,031.08-
  经营性应收项目的减少-209,296,572.2--53,994,851.18-
  经营性应付项目的增加-89,562,810.16-14,179,891.37-
  其他12,065,531.91--4,226,065.2-
  现金的期末余额672,378,096.26-844,725,390.32-
  减:现金的期初余额844,725,390.32-735,620,565.08-
  现金及现金等价物的净增加额-172,347,294.06-109,104,825.24-
公告日期2026-08-222026-04-282026-03-262025-10-29
审计意见(境内)标准无保留意见
TOP↑